Note: Ingredients listed on restricted chemical lists
EC/CAS
907204-31-3
Name of the chemical
3-(Difluormethyl)-1-methyl-N-(3‘,4’,5’-trifluorbiphenyl-2-yl)pyrazol-4-carboxamid; Fluxapyroxad (2020/1182)
Concentration
N/A
EC/CAS
125116-23-6
Name of the chemical
Metconazol (ISO); (1RS,5RS;1RS,5SR)-5-(4-Chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (790/2009)
Concentration
(W/W) 4.4 %
EC/CAS
200-664-3/67-68-5
Name of the chemical
dimethyl sulphoxide
Concentration
(W/W) < 15 %
General Information
Version
7.0
Revision date
2022-02-14
Product name
Librax
Emergency telephone
+49 180 2273-112
Icons in SDS
Company Information
company name
BASF SE
e-mail address of the competent person responsible for the Safety Data Sheet
product-safety-uk-and-ireland@basf.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319, H332, H361, H361d, H362, H400, H410
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
No 1272/2008 Classification of the substance or mixture For the classification of the mixture the following methods have been applied: extrapolation on the concentration levels of the hazardous substances, on basis of test results and after evaluation of experts. The methodologies used are mentioned at the respective test results According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Skin Sens. 1 H317 May cause an allergic skin reaction. Eye Dam./Irrit. 2 H319 Causes serious eye irritation. Acute Tox. 4 (Inhalation - mist) H332 Harmful if inhaled. Repr. 2 H361 Suspected of damaging the unborn child. Repr. Additional category for H362 May cause harm to breast-fed children. effects on or via lactation. Aquatic Acute 1 H400 Very toxic to aquatic life. Aquatic Chronic 1 H410 Very toxic to aquatic life with long lasting effects According to BASF current knowledge and application of the criteria given in Annex I of Regulation
2.2 Label elements
Globally Harmonized System (GHS) in accordance with UK regulations.
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H361d Suspected of damaging the unborn child. H362 May cause harm to breast-fed children. H410 Very toxic to aquatic life with long lasting effects. EUH401 To avoid risks to human health and the environment, comply with the instructions for use.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P103 Read carefully and follow all instructions. (Disposal) P501 Dispose of contents/container to a licensed hazardous-waste disposal contractor or collection site except for empty clean containers which can be disposed of as non-hazardous waste. According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Hazard determining component(s) for labelling: 1H-Pyrazole-4-carboxamide, 3-(difluoromethyl)-1- methyl-N-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-; Fluxapyroxad, metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, Propanoic acid, 2-hydroxy-, 2-ethylhexyl ester, (2S)-
Prevention
P280 Wear protective gloves/protective clothing/eye protection/face protection. P271 Use only outdoors or in a well-ventilated area. P260 Do not breathe mist or vapour or spray. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P272 Contaminated work clothing should not be allowed out of the workplace. P263 Avoid contact during pregnancy and while nursing. P264 Wash contaminated body parts thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P312 Call a POISON CENTER or physician if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P333 + P313 If skin irritation or rash occurs: Get medical attention. P362 + P364 Take off contaminated clothing and wash it before reuse. P308 + P311 IF exposed or concerned: Call a POISON CENTER or physician. P391 Collect spillage. P337 + P313 If eye irritation persists: Get medical attention.
Storage
P405 Store locked up.
2.3 Other hazards
According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 See section 12 - Results of PBT and vPvB assessment. If applicable information is provided in this section on other hazards which do not result in classification but which may contribute to the overall hazards of the substance or mixture.
2.1 Classification of the substance or mixture
For the classification of the mixture the following methods have been applied: extrapolation on the concentration levels of the hazardous substances, on basis of test results and after evaluation of experts. The methodologies used are mentioned at the respective test results. According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Skin Sens. 1 H317 May cause an allergic skin reaction. Eye Dam./Irrit. 2 H319 Causes serious eye irritation. Acute Tox. 4 (Inhalation - mist) H332 Harmful if inhaled. Repr. 2 H361 Suspected of damaging the unborn child. Repr. Additional category for H362 May cause harm to breast-fed children. effects on or via lactation. Aquatic Acute 1 H400 Very toxic to aquatic life. Aquatic Chronic 1 H410 Very toxic to aquatic life with long lasting effects. According to BASF current knowledge and application of the criteria given in Annex I of Regulation (EC) No. 1272/2008, the following classification exceeding the classification given in Regulation (EC) No 1272/2008, Annex VI, Table 3.1 is required. Acute Tox. 4 (Inhalation - mist) Eye Dam./Irrit. 2 Skin Sens. 1 Repr. Additional category for effects on or via lactation. Repr. 2 (unborn child) Aquatic Acute 1 Aquatic Chronic 1 For the classifications not written out in full in this section the full text can be found in section 16.